Thank you for subscribing!
Finfeed Archived Jul 01, 2021
Creso Pharma (ASX: CPH) has achieved strong sales growth for the June quarter generating a total of A$1,715,933 - a 24% increase on the previous quarter (Q1 CY2021: A$1,385,000).
Finfeed Archived Apr 08, 2021
Creso Pharma's (ASX: CPH) wholly-owned Canadian subsidiary, Mernova Medicinal has secured new purchase orders valued at C$145,192
Finfeed Archived Jan 29, 2021
Creso Pharma looks set to start the year on a strong note after an impressive performance in the December quarter of 2020
Finfeed Archived Dec 16, 2020
Creso Pharma's (ASX: CPH) Mernova Medicinal Inc. has secured an agreement with OCRC, formally recognising it as a supplier in Ontario
Get expert stock analysis direct in your inbox
Finfeed Archived Dec 09, 2020
Creso Pharma (ASX: CPH) has received three purchase orders with a combined value of C$275,023 with an order from Ontario pending.
Join Our Mailing List
